Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19
Abstract
:Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ilias, I.; Thomopoulos, C. Addressing delays in the diagnosis of pheochromocytoma/paraganglioma. Expert Rev. Endocrinol. Metab. 2019, 14, 359–363. [Google Scholar] [CrossRef] [PubMed]
- Gubbi, S.; Nazari, M.A.; Taieb, D.; Klubo-Gwiezdzinska, J.; Pacak, K. Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol. 2020, 8, 978–986. [Google Scholar] [CrossRef]
- Cerecer-Gil, N.Y.; Figuera, L.E.; Llamas, F.J.; Lara, M.; Escamilla, J.G.; Ramos, R.; Estrada, G.; Hussain, A.K.; Gaal, J.; Korpershoek, E.; et al. Mutation of SDHB is a cause of hypoxia-related high-altitude paraganglioma. Clin. Cancer Res. 2010, 16, 4148–4154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Papathomas, T.G.; Suurd, D.P.D.; Pacak, K.; Tischler, A.S.; Vriens, M.R.; Lam, A.K.; de Krijger, R.R. What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas? Endocr. Pathol. 2021, 32, 134–153. [Google Scholar] [CrossRef] [PubMed]
- West, J.B. Physiological Effects of Chronic Hypoxia. N. Engl. J. Med. 2017, 376, 1965–1971. [Google Scholar] [CrossRef] [PubMed]
- Kumar, H.; Choi, D.K. Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway? Mediat. Inflamm. 2015, 2015, 584758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bigham, A.W.; Lee, F.S. Human high-altitude adaptation: Forward genetics meets the HIF pathway. Genes Dev. 2014, 28, 2189–2204. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- van Patot, M.C.; Gassmann, M. Hypoxia: Adapting to high altitude by mutating EPAS-1, the gene encoding HIF-2α. High Alt. Med. Biol. 2011, 12, 157–167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Höpfl, G.; Ogunshola, O.; Gassmann, M. Hypoxia and high altitude. The molecular response. Adv. Exp. Med. Biol. 2003, 543, 89–115. [Google Scholar] [CrossRef] [PubMed]
- Zhang, R.; Wu, Y.; Zhao, M.; Liu, C.; Zhou, L.; Shen, S.; Liao, S.; Yang, K.; Li, Q.; Wan, H. Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 297, L631–L640. [Google Scholar] [CrossRef] [PubMed]
- Stephens, K.E.; Chernyavskiy, P.; Bruns, D.R. Impact of altitude on COVID-19 infection and death in the United States: A modeling and observational study. PLoS ONE 2021, 16, e0245055. [Google Scholar] [CrossRef] [PubMed]
- Pun, M.; Turner, R.; Strapazzon, G.; Brugger, H.; Swenson, E.R. Lower Incidence of COVID-19 at High Altitude: Facts and Confounders. High Alt. Med. Biol. 2020, 21, 217–222. [Google Scholar] [CrossRef] [PubMed]
- Arias-Reyes, C.; Zubieta-DeUrioste, N.; Poma-Machicao, L.; Aliaga-Raduan, F.; Carvajal-Rodriguez, F.; Dutschmann, M.; Schneider-Gasser, E.M.; Zubieta-Calleja, G.; Soliz, J. Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude? Respir. Physiol. Neurobiol. 2020, 277, 103443. [Google Scholar] [CrossRef] [PubMed]
- Prieto-Fernández, E.; Egia-Mendikute, L.; Vila-Vecilla, L.; Bosch, A.; Barreira-Manrique, A.; Lee, S.Y.; García-del Río, A.; Antoñana-Vildosola, A.; Jimenez-Lasheras, B.; Moreno-Cugnon, L.; et al. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate. Emerg. Microbes Infect. 2021, 10, 1065–1076. [Google Scholar] [CrossRef] [PubMed]
- Serebrovska, Z.O.; Chong, E.Y.; Serebrovska, T.V.; Tumanovska, L.V.; Xi, L. Hypoxia, HIF-1α, and COVID-19: From pathogenic factors to potential therapeutic targets. Acta Pharmacol. Sin. 2020, 41, 1539–1546. [Google Scholar] [CrossRef]
- Li, Y.; Zhou, W.; Yang, L.; You, R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol. Res. 2020, 157, 104833. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ilias, I.; Kaltsas, G.; Barkas, K.; Chrousos, G.P. Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19. Medicina 2021, 57, 1033. https://doi.org/10.3390/medicina57101033
Ilias I, Kaltsas G, Barkas K, Chrousos GP. Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19. Medicina. 2021; 57(10):1033. https://doi.org/10.3390/medicina57101033
Chicago/Turabian StyleIlias, Ioannis, Gregory Kaltsas, Konstantinos Barkas, and George P. Chrousos. 2021. "Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19" Medicina 57, no. 10: 1033. https://doi.org/10.3390/medicina57101033